Court of Appeal refuses injunction in cholesterol-reducing drug case

The Court of Appeal has by a 2-1 majority refused to grant an injunction preventing the distribution of a generic alternative to a cholesterol-reducing drug at less than one-tenth of its current price.

Pharmaceutical giant Merck Sharp and Dohme (MSD) got a temporary High Court injunction in April preventing rival Clonmel Healthcare from continue to sell a version of MSD's "Inegy" drug over alleged breach of trademark.